These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 18078676

  • 1. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
    Yang YF, Zhao W, Zhong YD, Yang YJ, Shen L, Zhang N, Huang P.
    Antiviral Res; 2008 Feb; 77(2):136-41. PubMed ID: 18078676
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
    You J, Zhuang L, Cheng HY, Yan SM, Yu L, Huang JH, Tang BZ, Huang ML, Ma YL, Chongsuvivatwong V, Sriplung H, Geater A, Qiao YW, Wu RX.
    World J Gastroenterol; 2006 Nov 07; 12(41):6715-21. PubMed ID: 17075991
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients.
    Dogan UB, Golge N, Akin MS.
    Eur J Gastroenterol Hepatol; 2013 Nov 07; 25(11):1312-6. PubMed ID: 23652913
    [Abstract] [Full Text] [Related]

  • 6. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
    Mutchnick MG, Lindsay KL, Schiff ER, Cummings GD, Appelman HD, Peleman RR, Silva M, Roach KC, Simmons F, Milstein S, Gordon SC, Ehrinpreis MN.
    J Viral Hepat; 1999 Sep 07; 6(5):397-403. PubMed ID: 10607256
    [Abstract] [Full Text] [Related]

  • 7. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov 07; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 8. IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection.
    Xie DY, Wang SM, Yang JM, Wang LH, Chen HY, Huai C, Shang J, Mao Q, Lei CL, Luo GH, Qian J, Lu DR.
    World J Gastroenterol; 2016 Nov 28; 22(44):9813-9821. PubMed ID: 27956805
    [Abstract] [Full Text] [Related]

  • 9. HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
    Vlachogiannakos J, Papatheodoridis GV.
    Liver Int; 2014 Feb 28; 34 Suppl 1():127-32. PubMed ID: 24373089
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.
    Chan HL, Tang JL, Tam W, Sung JJ.
    Aliment Pharmacol Ther; 2001 Dec 28; 15(12):1899-905. PubMed ID: 11736720
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.
    Saruc M, Ozden N, Turkel N, Ayhan S, Hock LM, Tuzcuoglu I, Yuceyar H.
    J Pharm Sci; 2003 Jul 28; 92(7):1386-95. PubMed ID: 12820143
    [Abstract] [Full Text] [Related]

  • 12. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
    You J, Zhuang L, Cheng HY, Yan SM, Qiao YW, Huang JH, Tang BZ, Ma YL, Wu GB, Qu JY, Wu RX.
    J Chin Med Assoc; 2005 Feb 28; 68(2):65-72. PubMed ID: 15759817
    [Abstract] [Full Text] [Related]

  • 13. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.
    Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM.
    Antivir Ther; 2006 Feb 28; 11(2):245-53. PubMed ID: 16640105
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
    Lee HW, Lee JI, Um SH, Ahn SH, Chang HY, Park YK, Hong SP, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2008 May 28; 23(5):729-35. PubMed ID: 18410608
    [Abstract] [Full Text] [Related]

  • 15. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 16. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
    Loggi E, Gramenzi A, Margotti M, Cursaro C, Galli S, Vitale G, Grandini E, Scuteri A, Vukotic R, Andreone P, Bernardi M.
    J Viral Hepat; 2008 Jun 10; 15(6):442-8. PubMed ID: 18221304
    [Abstract] [Full Text] [Related]

  • 17. [Antiviral therapy of chronic hepatitis B patients resistant to lamivudine].
    Cui SN, Wang MM.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec 10; 19(4):395-7. PubMed ID: 16416004
    [Abstract] [Full Text] [Related]

  • 18. [Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].
    Mao HY, Shi TD.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan 10; 19(1):29-33. PubMed ID: 21272455
    [Abstract] [Full Text] [Related]

  • 19. Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis.
    Kim V, Abreu RM, Nakagawa DM, Baldassare RM, Carrilho FJ, Ono SK.
    J Viral Hepat; 2016 Mar 10; 23(3):154-69. PubMed ID: 25967226
    [Abstract] [Full Text] [Related]

  • 20. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ, Fang F, Guo ZF, Chen Q.
    Zhonghua Er Ke Za Zhi; 2007 Aug 10; 45(8):592-8. PubMed ID: 18021533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.